Yu-Quan Li

Functional imaging beyond anatomy: The emerging role of magnetic resonance spectroscopy and metabolic biomarkers in monitoring targeted cancer therapy

It is argued that the field is transitioning from proof-of-principle pharmacodynamic studies toward standardised, biomarker-guided adaptive therapy, and that the principal barriers — technical harmonisation, quantification standards and prospective validation — are now well defined and addressable.